This document presents IQVIA's financial performance for the second quarter and first half of 2025, highlighting revenue growth, net income, and adjusted EBITDA. The report details segment-specific revenue contributions from Technology & Analytics Solutions (TAS), Research & Development Solutions (R&DS), and Contract Sales & Medical Solutions (CSMS), noting strong performance in TAS. Key metrics like R&D Solutions backlog and bookings are provided, indicating future business. Additionally, the document outlines the company's financial position, including cash, debt, and share repurchases, and offers updated full-year 2025 financial guidance. The report also includes reconciliations of non-GAAP financial measures to comparable GAAP figures, along with cautionary statements regarding forward-looking information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana